Evidence map›Paper›PMID 31010415›Full record

ArticleJournal of ovarian research2019

Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.

Hao Feng, Zhong-Yi Gu, Qin Li, Qiong-Hua Liu, Xiao-Yu Yang, Jun-Jie Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of ovarian research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 156 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Hao FengDepartment of Gynecology and Obstetrics, Obstetrics and Gynecology Hospital of Fudan University, #128 Shenyang Road, Shanghai, 200090, China.
Zhong-Yi GuDepartment of Gynaecology and Obstetrics, Changhai Hospital, Navy Medical University, #168 Changhai Road, Shanghai, 200433, China.
Qin LiDepartment of Gynaecology and Obstetrics, Changhai Hospital, Navy Medical University, #168 Changhai Road, Shanghai, 200433, China.
Qiong-Hua LiuDepartment of Gynaecology, Aoyang Hospital Affiliated to Jiangsu University, #279 Jingang Road, Zhangjiagang, 215600, Jiangsu, China.
Xiao-Yu YangDepartment of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, #225 Changhai Road, Shanghai, 200438, China. Ehbh_yangxy@163.com.
Jun-Jie ZhangDepartment of Gynaecology and Obstetrics, Changhai Hospital, Navy Medical University, #168 Changhai Road, Shanghai, 200433, China. zhangjj910@163.com.
Second Military Medical University · CNChanghai Hospital · CNEastern Hepatobiliary Surgery Hospital · CNJiangsu University · CNObstetrics and Gynecology Hospital of Fudan University · CN

Funding

National Natural Science Foundation of China 81571387
6 · The paper itself

Abstract

Ovarian cancer (OC) is the highest frequent malignant gynecologic tumor with very complicated pathogenesis. The purpose of the present academic work was to identify significant genes with poor outcome and their underlying mechanisms. Gene expression profiles of GSE36668, GSE14407 and GSE18520 were available from GEO database. There are 69 OC tissues and 26 normal tissues in the three profile datasets. Differentially expressed genes (DEGs) between OC tissues and normal ovarian (OV) tissues were picked out by GEO2R tool and Venn diagram software. Next, we made use of the Database for Annotation, Visualization and Integrated Discovery (DAVID) to analyze Kyoto Encyclopedia of Gene and Genome (KEGG) pathway and gene ontology (GO). Then protein-protein interaction (PPI) of these DEGs was visualized by Cytoscape with Search Tool for the Retrieval of Interacting Genes (STRING). There were total of 216 consistently expressed genes in the three datasets, including 110 up-regulated genes enriched in cell division, sister chromatid cohesion, mitotic nuclear division, regulation of cell cycle, protein localization to kinetochore, cell proliferation and Cell cycle, progesterone-mediated oocyte maturation and p53 signaling pathway, while 106 down-regulated genes enriched in palate development, blood coagulation, positive regulation of transcription from RNA polymerase II promoter, axonogenesis, receptor internalization, negative regulation of transcription from RNA polymerase II promoter and no significant signaling pathways. Of PPI network analyzed by Molecular Complex Detection (MCODE) plug-in, all 33 up-regulated genes were selected. Furthermore, for the analysis of overall survival among those genes, Kaplan-Meier analysis was implemented and 20 of 33 genes had a significantly worse prognosis. For validation in Gene Expression Profiling Interactive Analysis (GEPIA), 15 of 20 genes were discovered highly expressed in OC tissues compared to normal OV tissues. Furthermore, four genes (BUB1B, BUB1, TTK and CCNB1) were found to significantly enrich in the cell cycle pathway via re-analysis of DAVID. In conclusion, we have identified four significant up-regulated DEGs with poor prognosis in OC on the basis of integrated bioinformatical methods, which could be potential therapeutic targets for OC patients.

Indexed as

Computational BiologyFemaleHumansOvarian NeoplasmsPrognosisSurvival AnalysisBioinformatical analysisDifferentially expressed geneMicroarrayOvarian cancer

Identifiers

PMID31010415
PMCPMC6477749
OpenAlexW2945274796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.